Istari Oncology
Durham, United States (US) · Health and Medical
Do your work at Istari Oncology?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Istari Oncology is a Durham, North Carolina-based biotechnology company developing innovative immunotherapy treatments for glioblastoma and other cancers.Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies.
Overview
Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.
Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.
Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
Contact Details
Durham, United States (US), 6 Davis Dr
Founded
2016
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after Istari Oncology
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.